Ignore Big Pharma's Faux 'Facts,' HHS Says In Kickback Clash
Drugmakers are skewing basic issues in closely watched litigation over health care kickbacks by presenting "irrelevant material" and "slanted characterizations" as undisputed facts, federal health care officials told a Virginia federal...To view the full article, register now.
Already a subscriber? Click here to view full article